153 related articles for article (PubMed ID: 37764419)
1. Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study.
Kadela-Tomanek M; Krzykawski K; Halama A; Kubina R
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764419
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
[TBL] [Abstract][Full Text] [Related]
3. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
[TBL] [Abstract][Full Text] [Related]
4. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anticancer activity of naphthoquinone derivatives.
Shen XB; Wang Y; Han XZ; Sheng LQ; Wu FF; Liu X
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):773-785. PubMed ID: 32200656
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
7. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
8. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
9. Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and
Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):86-99. PubMed ID: 34894963
[TBL] [Abstract][Full Text] [Related]
10. 5-Oxo-hexahydroquinoline and 5-oxo-tetrahydrocyclopentapyridine derivatives as promising antiproliferative agents with potential apoptosis-inducing capacity.
Ranjbar S; Khoshneviszadeh M; Tavakkoli M; Miri R; Edraki N; Firuzi O
Mol Divers; 2022 Jun; 26(3):1481-1500. PubMed ID: 34671894
[TBL] [Abstract][Full Text] [Related]
11. Novel 2-amino-1,4-naphthoquinone hybrids: Design, synthesis, cytotoxicity evaluation and in silico studies.
Gholampour M; Seradj H; Pirhadi S; Khoshneviszadeh M
Bioorg Med Chem; 2020 Nov; 28(21):115718. PubMed ID: 33065435
[TBL] [Abstract][Full Text] [Related]
12. Novel fused imidazotriazines acting as promising top. II inhibitors and apoptotic inducers with greater selectivity against head and neck tumors: Design, synthesis, and biological assessments.
Al-Karmalawy AA; Rashed M; Sharaky M; Abulkhair HS; Hammouda MM; Tawfik HO; Shaldam MA
Eur J Med Chem; 2023 Nov; 259():115661. PubMed ID: 37482023
[TBL] [Abstract][Full Text] [Related]
13. The design, synthesis, biological evaluation, and molecular docking of new 5-aminosalicylamide-4-thiazolinone hybrids as anticancer agents.
Othman SA; Abou-Ghadir OF; Ramadan WS; Mostafa YA; El-Awady R; Abdu-Allah HHM
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300315. PubMed ID: 37551741
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA
Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
16. New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation.
El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; F Kassem A
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080455
[TBL] [Abstract][Full Text] [Related]
17. Design and novel synthetic approach supported with molecular docking and biological evidence for naphthoquinone-hydrazinotriazolothiadiazine analogs as potential anticancer inhibiting topoisomerase-IIB.
Mohamady S; Gibriel AA; Ahmed MS; Hendy MS; Naguib BH
Bioorg Chem; 2020 Mar; 96():103641. PubMed ID: 32032844
[TBL] [Abstract][Full Text] [Related]
18. New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies.
Abd El-Wahab HAA; Mansour HS; Ali AM; El-Awady R; Aboul-Fadl T
Bioorg Chem; 2022 Mar; 120():105622. PubMed ID: 35091290
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
Bajaj S; Kumar MS; Tinwala H; Yc M
Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]